Clinical trial
Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
NCT00001483 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00001483 |
|---|---|
| Title | Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression |
| Official title | Acute Efficacy of Bupropion, Sertraline, and Venlafaxine as Adjuvant Treatment to Mood Stabilizers in Bipolar Depression: A Randomized, Double-Blind, Comparative Study |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Depressive Disorder |
| Intervention type | Drug |
| Interventions | buproprion (Wellbutrin), sertraline (Zoloft), venlafaxine (Effexor) |
| Enrollment | 75 |
| Start date | Jun 1, 1995 |
| Completion | May 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: